Search Immortality Topics:

Page 11234..1020..»

Category Archives: Pharmacogenomics

Intermountain lab expands precision medicine with …

Intermountain Precision Genomics Core Laboratory announced today it is expanding RxMatch. The pharmacogenomics service the study of how genes affect a patients response to medication will be made available to all Intermountain Healthcare providers. Continue reading

Posted in Pharmacogenomics | Comments Off on Intermountain lab expands precision medicine with …

April 16: Pharmacogenomics – National Human Genome …

PharmacogenomicsChoosing the right medication at the right dose for each patient April 16, 2018 Did you know … Continue reading

Posted in Pharmacogenomics | Comments Off on April 16: Pharmacogenomics – National Human Genome …

Omics – Wikipedia

The English-language neologism omics informally refers to a field of study in biology ending in -omics, such as genomics, proteomics or metabolomics. The related suffix -ome is used to address the objects of study of such fields, such as the genome, proteome or metabolome respectively Continue reading

Posted in Pharmacogenomics | Comments Off on Omics – Wikipedia

Ion AmpliSeq Designer

AmpliSeq On-Demand Panels: Coming up with different design combinations for a panel requires time and effort. And you guys are doing all the work I like the idea of ordering only the genes that I see more – Dr. William G Continue reading

Posted in Pharmacogenomics | Comments Off on Ion AmpliSeq Designer

Pharmacogenomics – NCPA

General Description, Overview, and Opportunities Pharmacogenomics has increasingly become an area of interest to clinicians because of the potential to tailor pharmacotherapy based on genetic variations in patients. Pharmacogenomics is one of the key aspects of personalized medicine, focusing on how an individual’s DNA affects the way they respond to medications Continue reading

Posted in Pharmacogenomics | Comments Off on Pharmacogenomics – NCPA

CYP2C9 – Wikipedia

Cytochrome P450 2C9 (abbreviated CYP2C9) is an enzyme that in humans is encoded by the CYP2C9 gene.[5][6] CYP2C9 is an important cytochrome P450 enzyme with a major role in the oxidation of both xenobiotic and endogenous compounds. CYP2C9 makes up about 18% of the cytochrome P450 protein in liver microsomes (data only for antifungal). Some 100 therapeutic drugs are metabolized by CYP2C9, including drugs with a narrow therapeutic index such as warfarin and phenytoin and other routinely prescribed drugs such as acenocoumarol, tolbutamide, losartan, glipizide, and some nonsteroidal anti-inflammatory drugs. Continue reading

Posted in Pharmacogenomics | Comments Off on CYP2C9 – Wikipedia